NCT00130845View on ClinicalTrials.gov

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

PHASE3CompletedINTERVENTIONAL

Enrollment

312

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Diabetic Retinopathy

Interventions

DRUG

Octreotide Acetate in Microspheres

DRUG

Placebo

Trial Locations (1)

07936

Novartis, East Hanover

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY